Professor emerita Auburn University Auburn, Alabama, United States
Presentation Description / Summary: The current knowledge of hypersomatotropism/acromegaly in cats and SGLT2i inhibitors will be reviewed. The use of SGLT2 inhibitors in acromegalic diabetic cats will be considered specifically, with presentation of new data. How use of SGLT2 inhibitors in diabetic cats with acromegaly differs from that in diabetic cats without acromegaly will be considered. The effectiveness of SGLT2i in hypersomatotropism-associated diabetes likely also holds a greater message about the potential of SGLT2 inhibitors in any condition resulting in or associated with insulin resistance and/or glucose intolerance.
Learning Objectives:
Explain use of SGLT2 inhibitors in diabetic cats.
Recognize acromegaly/hypersomatotropism in cats and diagnose it accurately.
Discuss the differences in treating diabetic cats with and without acromegaly/hypersomatotropism.
